Evidence map›Paper›PMID 16919674›Full record

ArticleJournal of electrocardiology2006

The effects of caffeine on the inducibility of atrial fibrillation.

Abdul Rashid, Mujahid Hines, Benjamin J Scherlag, William S Yamanashi, William Lovallo

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of electrocardiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05464940 (Impact of Intravenous Caffeine on Atrial Electrical Properties and Potential Arrythmia Induction in Patients With Paroxysmal Atrial Fibrillation), which is not on this map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05464940 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Impact of Intravenous Caffeine on Atrial Electrical Properties and Potential Arrythmia Induction in Patients With Paroxysmal Atrial Fibrillation: The COFFEE-AF Trial

TypeinterventionalSponsorKansas City Heart Rhythm Research FoundationRan2025 to 2026Enrolled100ConditionsAtrial FibrillationArmsIntravenous caffeine, Masked Placebo
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2017
    Guideline
  2. Guideline
  3. Pooled it
  4. Caffeine consumption and incident atrial fibrillation in women.The American journal of clinical nutrition · 2010
    Trial
  5. Review
  6. Review
  7. Article
  8. European Cardiac Arrhythmia Society Statement on the cardiovascular events associated with the use or abuse of energy drinks.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2019
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Abdul RashidDepartment of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Mujahid Hines
Benjamin J Scherlag
William S Yamanashi
William Lovallo
University of Oklahoma Health Sciences Center · US

Funding

CAFFEINE INFLUENCES ON EXERCISE &PSYCHOLOGICAL STRESSR01HL032050 · NHLBI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI LOVALLO, WILLIAM R · 1985 to 2004
$2.1M
NHLBI NIH HHS HL 32050NHLBI NIH HHS R01 HL032050
6 · The paper itself

Abstract

introductionThere is widespread belief that caffeine consumption is linked to atrial arrhythmias; however, there is a relative lack of systematic evidence to support the assertion. The purpose of this study was to investigate whether caffeine, in doses equivalent to daily use in the general population, alter the propensity for atrial fibrillation (AF) in an experimental model comparing normal and simulated predisposition to AF. METHODS AND MATERIAL: Caffeine (caffeine Na benzoate, 50:50 mixture) was administered intravenously at 1, 3, and 5 mg/kg doses in dogs producing serum levels of 2 to 4, 5 to 7, and 8 to 10 microg/mL. To simulate focal AF, premature stimulation from the right superior pulmonary vein was delivered at 2x, 4x, and 10x threshold at a rate of 180/min (S(1)-S(2) = 330 milliseconds) without and then with low-level stimulation of ganglionated plexi (GP) at the entrance of the right superior pulmonary vein. The window of vulnerability (WOV), a measure of the propensity for AF inducibility, was determined by the longest coupling interval of the premature beat (S(1)-S(2)) minus the shortest S(1)-S(2), which induced AF. The cumulative WOV is the sum of the individually determined WOV.

resultsAt each serum level of caffeine, the cumulative WOV was lower without rather than with GP stimulation compared with control. The cumulative WOV for both the stimulated, that is, predisposed to AF, and nonstimulated, that is, normal groups, exhibited a significantly lower average as compared with that exhibited by the control group (P <or= .003-.02).

conclusionThese findings suggest that the presence of caffeine may result in an unexpected reduction in the propensity for AF in healthy individuals and in those with a predisposition for AF (enhanced AF inducibility caused by the stimulation of the GP).

Indexed as

AnimalsAtrial FibrillationCaffeineDogsDose-Response Relationship, DrugElectrocardiographyRisk AssessmentRisk FactorsCaffeine

Identifiers

PMID16919674
PMCPMC2257921
OpenAlexW2086978490

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.